SAB Biotherapeutics (SABS) Notes Payables (2020 - 2025)
SAB Biotherapeutics (SABS) posted Notes Payables of $138554.0 for Q1 2025, down 49.77% on a QoQ basis from $275849.0 in Q4 2024, and down 83.42% year-over-year from $835467.0 in Q1 2024.
SAB Biotherapeutics (SABS) Notes Payables (2020 - 2025) Analysis & Trends
SAB Biotherapeutics' Notes Payables history runs 6 years deep, the most recent figure standing at $138554.0 for Q1 2025.
- Quarterly Notes Payables fell 83.42% year-over-year to $138554.0 in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $138554.0 (down 83.42% YoY) and the FY2024 annual result came in at $275849.0, down 73.75% from the prior year.
- Notes Payables was $138554.0 for Q1 2025 at SAB Biotherapeutics, down from $275849.0 in the prior quarter.
- Across five years, Notes Payables topped out at $1.8 million in Q4 2021 and bottomed at $25013.0 in Q3 2022.
- A 5-year average of $609781.8 and a median of $541644.0 in 2023 frame the typical range for Notes Payables.
- Annual changes were most pronounced in 2023 — Notes Payables surged 2065.45% — and 2025, when it sank 83.42%.
- SAB Biotherapeutics' Notes Payables stood at $1.8 million in 2021, then slumped by 57.0% to $772665.0 in 2022, then soared by 36.0% to $1.1 million in 2023, then slumped by 73.75% to $275849.0 in 2024, then tumbled by 49.77% to $138554.0 in 2025.
- Business Quant data shows SABS's Notes Payables at $138554.0 in Q1 2025, $275849.0 in Q4 2024, and $615818.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | SAB Biotherapeutics | 170.64 Mn | 170.64 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 138,554.00 |
| Dec 31, 2024 | 275,849.00 |
| Jun 30, 2024 | 615,818.00 |
| Mar 31, 2024 | 835,467.00 |
| Dec 31, 2023 | 1.05 Mn |
| Sep 30, 2023 | 541,644.00 |
| Jun 30, 2023 | 111,894.00 |
| Mar 31, 2023 | 444,478.00 |
| Dec 31, 2022 | 772,665.00 |
| Sep 30, 2022 | 25,013.00 |
| Jun 30, 2022 | 278,441.00 |
| Mar 31, 2022 | 1.04 Mn |
| Dec 31, 2021 | 1.80 Mn |
| Dec 31, 2020 | 538,731.00 |